Africa Molecular Diagnostics Market Size (2024 - 2029)

The Africa Molecular Diagnostics Market is projected to experience significant growth over the forecast period, driven by an increasing demand for point-of-care diagnostics and the rising burden of bacterial and viral diseases in the region. The market's expansion is supported by funding from international organizations, which aids in enhancing diagnostic capabilities and addressing the high disease burden. Despite challenges such as the high cost of diagnostics and a shortage of trained healthcare professionals, the need for accurate and rapid diagnostics, particularly in sub-Saharan Africa, underscores the potential for market growth. Government initiatives aimed at improving healthcare access are also expected to contribute to the market's development.

Market Size of Africa Molecular Diagnostics Industry

Africa Molecular Diagnostics Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 349.28 Million
Market Size (2029) USD 504.68 Million
CAGR (2024 - 2029) 7.64 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Africa Molecular Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Africa Molecular Diagnostics Market Analysis

The Africa Molecular Diagnostics Market size is estimated at USD 349.28 million in 2024, and is expected to reach USD 504.68 million by 2029, growing at a CAGR of 7.64% during the forecast period (2024-2029).

Some of the key factors driving the growth of the molecular diagnostics market in Africa include the growing demand for point-of-care diagnostics in the region, the growing burden of bacterial and viral diseases, and countries receiving funding from international organizations in the molecular diagnostics space.

The high disease burden in Africa creates a strong need for accurate and rapid diagnostics. For instance, an article published by Dove Press in July 2022 stated that, in sub-Saharan Africa (SSA), prevalence rates ranging from 14.7% to 82% were reported in countries like Nigeria, Gabon, Burkina Faso, Kenya, South Africa, and Tanzania. Children under the age of five have the highest risk of bacterial as well as viral infection in the region. Transmission is via the fecal route, either directly through person-to-person contact or indirectly through contaminated food and water. To cope with the rising burden of bacterial diseases, the region's diagnostic industry is taking steps that are expected to boost the demand for the molecular diagnostics market in Africa.

Furthermore, African countries are getting assistance from various organizations and associations, which is a beneficial factor in market growth. For instance, in July 2022, the World Bank approved a USD 100 million support program for the Africa Centre for Disease Control (Africa CDC) to enhance the institution’s technical capacity and strengthen its institutional framework to intensify support to African countries to prepare for detecting and responding to disease outbreaks and public health emergencies. With such funding from international organizations, the market for molecular diagnostics is expected to grow strongly during the forecast period.

Many African regions lack well-equipped healthcare facilities and trained personnel. There is a large gap between diagnostic needs and diagnostic access across much of sub-Saharan Africa (SSA), particularly for infectious diseases that inflict a substantial burden of morbidity. For instance, in an article published by PLOS Digital Health in June 2022, at least 50% of the population does not have access to essential health services. Advances in molecular diagnostics can accelerate healthcare provision toward Universal Health Coverage (UHC), bringing high-quality diagnostics and decision-support tools to the point of care. Hence, in the African region, many people lacking essential health services will further raise the need for molecular diagnostic services with the help of government initiatives anticipated to fuel the market's growth in the forecast period.

However, the high cost of disease diagnostics and the lack of trained healthcare professionals are expected to hamper the market growth in the coming years.

Africa Molecular Diagnostics Industry Segmentation

As per the scope of the report, molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphisms (SNP), deletions, rearrangements, insertions, and others), which may or may not be associated with diseases. Molecular diagnostics has been revolutionized over the past few decades. Africa Molecular Diagnostics Market is segmented by technology, application, product, end user, and geography. The market is segmented by technology into in situ hybridization, chips and microarrays, mass spectrometry (MS), sequencing, PCR, and other technologies. The market is segmented by application into infectious disease, oncology, pharmacogenomics, microbiology, genetic disease screening, human leukocyte antigen typing, and blood screening. By product, the market is segmented into instruments, reagents, and other products. By end user, the market is segmented into hospitals, laboratories, and other end users. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Technology
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry (MS)
Sequencing
PCR
Other Technologies
By Application
Infectious Diseases
Oncology
Pharmacogenomics
Microbiology and Genetic Disease Screening
Human Leukocyte Antigen Typing
Blood Screening
By Product
Instruments
Reagents
Other Products
By End User
Hospitals
Laboratories
Other End Users
Geography
South Africa
Nigeria
Rest of Africa
Need A Different Region Or Segment?
Customize Now

Africa Molecular Diagnostics Market Size Summary

The molecular diagnostics market in Africa is poised for significant growth, driven by an increasing demand for point-of-care diagnostics and the rising burden of bacterial and viral diseases. The high prevalence of infectious diseases, particularly in sub-Saharan Africa, underscores the need for rapid and accurate diagnostic solutions. International funding and support from organizations like the World Bank and Africa CDC are bolstering the market, enhancing the region's capacity to detect and respond to health emergencies. Despite challenges such as limited access to healthcare facilities and trained personnel, advancements in molecular diagnostics are expected to bridge the gap, supporting efforts toward Universal Health Coverage. The oncology segment is also experiencing growth due to the rising cancer burden and initiatives aimed at early disease diagnosis, further propelling the demand for molecular diagnostic products.

South Africa stands out as a key player in the African molecular diagnostics market, with significant investments from global companies and a focus on chronic disease management, particularly HIV. The country's efforts to integrate advanced diagnostic technologies and initiatives like Africa PGI 2.0 are expected to drive market expansion. The competitive landscape is moderately dynamic, with major players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific actively investing in the region. Partnerships and product launches, such as those by Alveo Technologies and Audere, are enhancing the availability of molecular diagnostic solutions. As the market continues to evolve, it is anticipated that both small and mid-sized companies will gain traction, contributing to the market's growth trajectory in the coming years.

Explore More

Africa Molecular Diagnostics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Demand for Point-of-Care Diagnostics in the Region

      2. 1.2.2 Increasing Burden of Bacterial and Viral Diseases

      3. 1.2.3 Technological Advancements in Molecular Diagnostics Space

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Disease Diagnostics

      2. 1.3.2 Lack of Trained Healthcare Professionals

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Technology

      1. 2.1.1 In Situ Hybridization

      2. 2.1.2 Chips and Microarrays

      3. 2.1.3 Mass Spectrometry (MS)

      4. 2.1.4 Sequencing

      5. 2.1.5 PCR

      6. 2.1.6 Other Technologies

    2. 2.2 By Application

      1. 2.2.1 Infectious Diseases

      2. 2.2.2 Oncology

      3. 2.2.3 Pharmacogenomics

      4. 2.2.4 Microbiology and Genetic Disease Screening

      5. 2.2.5 Human Leukocyte Antigen Typing

      6. 2.2.6 Blood Screening

    3. 2.3 By Product

      1. 2.3.1 Instruments

      2. 2.3.2 Reagents

      3. 2.3.3 Other Products

    4. 2.4 By End User

      1. 2.4.1 Hospitals

      2. 2.4.2 Laboratories

      3. 2.4.3 Other End Users

    5. 2.5 Geography

      1. 2.5.1 South Africa

      2. 2.5.2 Nigeria

      3. 2.5.3 Rest of Africa

Africa Molecular Diagnostics Market Size FAQs

The Africa Molecular Diagnostics Market size is expected to reach USD 349.28 million in 2024 and grow at a CAGR of 7.64% to reach USD 504.68 million by 2029.

In 2024, the Africa Molecular Diagnostics Market size is expected to reach USD 349.28 million.

Africa Molecular Diagnostics Market Size & share Analysis - Growth, Trends, & Forecasts (2024-2029)